Keurig Dr Pepper Inc. (NASDAQ:KDP - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seventeen research firms that are presently covering the stock, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation, twelve have assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $39.33.
Several brokerages have issued reports on KDP. Morgan Stanley raised shares of Keurig Dr Pepper from an "equal weight" rating to an "overweight" rating and boosted their target price for the company from $38.00 to $40.00 in a research note on Tuesday, April 1st. Royal Bank of Canada restated an "outperform" rating and set a $42.00 price target on shares of Keurig Dr Pepper in a research note on Tuesday, April 22nd. UBS Group upped their target price on Keurig Dr Pepper from $40.00 to $42.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. JPMorgan Chase & Co. lifted their target price on shares of Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an "overweight" rating in a report on Wednesday, February 26th. Finally, Argus initiated coverage on Keurig Dr Pepper in a research report on Wednesday, April 16th. They issued a "buy" rating and a $40.00 price objective for the company.
View Our Latest Report on KDP
Keurig Dr Pepper Stock Performance
KDP stock traded up $0.20 during midday trading on Monday, reaching $32.97. The company had a trading volume of 8,810,947 shares, compared to its average volume of 10,764,886. The company has a quick ratio of 0.36, a current ratio of 0.53 and a debt-to-equity ratio of 0.50. The stock has a 50 day moving average price of $34.03 and a 200 day moving average price of $33.07. The firm has a market capitalization of $44.78 billion, a PE ratio of 19.98, a P/E/G ratio of 2.42 and a beta of 0.48. Keurig Dr Pepper has a fifty-two week low of $30.12 and a fifty-two week high of $38.28.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its earnings results on Thursday, April 24th. The company reported $0.42 earnings per share for the quarter, beating the consensus estimate of $0.38 by $0.04. Keurig Dr Pepper had a return on equity of 10.45% and a net margin of 15.04%. The firm had revenue of $3.64 billion for the quarter, compared to the consensus estimate of $3.57 billion. During the same quarter in the previous year, the business earned $0.38 EPS. The firm's revenue for the quarter was up 4.8% on a year-over-year basis. Analysts anticipate that Keurig Dr Pepper will post 1.92 earnings per share for the current year.
Keurig Dr Pepper Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, July 11th. Stockholders of record on Friday, June 27th will be given a dividend of $0.23 per share. This represents a $0.92 annualized dividend and a dividend yield of 2.79%. The ex-dividend date of this dividend is Friday, June 27th. Keurig Dr Pepper's dividend payout ratio is 83.64%.
Insider Activity at Keurig Dr Pepper
In related news, Director De Ven Michael G. Van purchased 15,000 shares of Keurig Dr Pepper stock in a transaction dated Wednesday, June 4th. The stock was bought at an average price of $33.20 per share, for a total transaction of $498,000.00. Following the completion of the acquisition, the director now directly owns 15,000 shares of the company's stock, valued at $498,000. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Robert James Gamgort sold 208,000 shares of the firm's stock in a transaction on Tuesday, April 29th. The stock was sold at an average price of $33.96, for a total transaction of $7,063,680.00. Following the sale, the director now owns 3,054,490 shares in the company, valued at approximately $103,730,480.40. The trade was a 6.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 698,500 shares of company stock worth $23,591,400 over the last ninety days. Company insiders own 0.40% of the company's stock.
Hedge Funds Weigh In On Keurig Dr Pepper
Large investors have recently added to or reduced their stakes in the company. LaFleur & Godfrey LLC bought a new position in shares of Keurig Dr Pepper in the 4th quarter valued at about $806,000. Sumitomo Mitsui Trust Group Inc. grew its stake in Keurig Dr Pepper by 8.4% in the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,138,111 shares of the company's stock valued at $100,796,000 after purchasing an additional 242,315 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd increased its position in shares of Keurig Dr Pepper by 12.6% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 146,722 shares of the company's stock worth $4,713,000 after purchasing an additional 16,439 shares during the last quarter. Apollon Wealth Management LLC boosted its holdings in shares of Keurig Dr Pepper by 29.9% in the 4th quarter. Apollon Wealth Management LLC now owns 24,900 shares of the company's stock valued at $800,000 after buying an additional 5,729 shares during the last quarter. Finally, Empowered Funds LLC grew its stake in shares of Keurig Dr Pepper by 12.2% in the fourth quarter. Empowered Funds LLC now owns 20,060 shares of the company's stock valued at $644,000 after buying an additional 2,188 shares in the last quarter. Institutional investors own 93.99% of the company's stock.
About Keurig Dr Pepper
(
Get Free ReportKeurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.